MINNEAPOLIS (April 17, 2023) — Visura Technologies, Inc., a medical device company dedicated to delivering state-of-the-art visualization solutions to improve the safety and success of transesophogeal echocardiogram (TEE) probe intubation announced today the addition of Greg Swanson as Senior Vice President of Sales to support US commercialization efforts. Mr. Swanson joins the Visura team at a time of fast-paced growth for the company as they look to expand the TEECAD footprint across the US. The TEECAD System is the world’s first, FDA-cleared disposable camera that seamlessly connects to TEE probes, providing physicians with real-time visualization during TEE intubation to support first pass intubation success and reduce TEE procedural complications.
Mr. Swanson is an experienced medical device sales and marketing professional bringing over 25 years of experience to the Visura team. He has led high-performing teams at large, global medical device organizations as well as at small cap emerging medical device companies. He has launched multiple products across market segments such as endoscopy, cardiology, neurovascular, and capital and consumable products. Mr. Swanson has held positions of executive leadership with Boston Scientific, Stryker, Cantel Medical, and recently, was the Chief Marketing Officer at Ambu A/S, a market leader in the development of single use endoscope products.
“This is an exciting time for Visura as interest in our TEECAD system is growing dramatically,” stated Christine Horton, President and CEO of Visura. “Greg brings extensive medical device commercialization expertise to the team and we are excited to have him leading our sales team as we focus on expanding US product adoption.”
Visura’s TEECAD System is the world’s first FDA-cleared disposable camera that seamlessly connects to TEE probes. TEECAD provides physicians with real-time visualization during esophageal intubation for more efficient and effective probe placement. There are an estimated 700,000 TEE procedures performed annually in the U.S. with TEE procedures growing at an annual rate of 14%. Use of the TEECAD System for efficient and accurate probe placement with fewer complications supports the healthcare system’s goal of zero hospital-acquired complications.
About Visura Technologies, Inc.
Founded in 2015, Visura is a privately-held medical device company dedicated to delivering state-of-art visualization solutions to improve the safety and success of TEE probe intubation. They have developed TEECAD, the world’s first and only, FDA-cleared, disposable camera that seamlessly connects to a TEE probe, providing physicians real-time visualization for more efficient and effective probe placement to support safer intubation. For more information, please visit www.visuratechnologies.com.
